FR2501207B1 - Composes quinazoliniques antitumoraux et leur procede de production - Google Patents

Composes quinazoliniques antitumoraux et leur procede de production

Info

Publication number
FR2501207B1
FR2501207B1 FR8201979A FR8201979A FR2501207B1 FR 2501207 B1 FR2501207 B1 FR 2501207B1 FR 8201979 A FR8201979 A FR 8201979A FR 8201979 A FR8201979 A FR 8201979A FR 2501207 B1 FR2501207 B1 FR 2501207B1
Authority
FR
France
Prior art keywords
quinazolinic
tumor
compounds
producing
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8201979A
Other languages
English (en)
French (fr)
Other versions
FR2501207A1 (fr
Inventor
William E Kreighbaum
William T Comer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2501207A1 publication Critical patent/FR2501207A1/fr
Application granted granted Critical
Publication of FR2501207B1 publication Critical patent/FR2501207B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8201979A 1981-03-06 1982-02-08 Composes quinazoliniques antitumoraux et leur procede de production Expired FR2501207B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/241,317 US4343940A (en) 1979-02-13 1981-03-06 Anti-tumor quinazoline compounds

Publications (2)

Publication Number Publication Date
FR2501207A1 FR2501207A1 (fr) 1982-09-10
FR2501207B1 true FR2501207B1 (fr) 1985-12-06

Family

ID=22910195

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8201979A Expired FR2501207B1 (fr) 1981-03-06 1982-02-08 Composes quinazoliniques antitumoraux et leur procede de production

Country Status (31)

Country Link
US (1) US4343940A (online.php)
JP (1) JPS57158780A (online.php)
KR (1) KR880001852B1 (online.php)
AR (1) AR231138A1 (online.php)
AT (1) AT380476B (online.php)
AU (1) AU556099B2 (online.php)
BE (1) BE891936A (online.php)
CA (1) CA1163995A (online.php)
CH (1) CH647776A5 (online.php)
CY (1) CY1371A (online.php)
DE (1) DE3203770C2 (online.php)
DK (1) DK159442C (online.php)
ES (1) ES8304095A1 (online.php)
FI (1) FI71559C (online.php)
FR (1) FR2501207B1 (online.php)
GB (1) GB2094295B (online.php)
GR (1) GR75903B (online.php)
HK (1) HK4588A (online.php)
HU (1) HU189997B (online.php)
IE (1) IE52385B1 (online.php)
IL (1) IL64875A0 (online.php)
IT (1) IT1154272B (online.php)
KE (1) KE3715A (online.php)
LU (1) LU83903A1 (online.php)
NL (1) NL8200473A (online.php)
NZ (1) NZ199576A (online.php)
PH (1) PH18529A (online.php)
PT (1) PT74394B (online.php)
SE (1) SE461732B (online.php)
SG (1) SG30787G (online.php)
YU (1) YU42031B (online.php)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5030635A (en) * 1990-02-14 1991-07-09 Ortho Pharmaceutical Corporation 6-7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
USRE37650E1 (en) 1991-05-10 2002-04-09 Aventis Pharmacetical Products, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5714493A (en) * 1991-05-10 1998-02-03 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
PL315941A1 (en) * 1994-02-23 1996-12-09 Pfizer 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
US5804396A (en) * 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
TW321649B (online.php) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
EP0824525B1 (en) * 1995-04-27 2001-06-13 AstraZeneca AB Quinazoline derivatives
DE69618587T2 (de) * 1995-06-07 2002-08-29 Sugen, Inc. Chinazoline und pharmazeutische zusammensetzungen
WO1997017329A1 (en) * 1995-11-07 1997-05-15 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
US7119174B2 (en) * 1995-12-18 2006-10-10 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
WO1997030035A1 (en) 1996-02-13 1997-08-21 Zeneca Limited Quinazoline derivatives as vegf inhibitors
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
ES2169355T3 (es) 1996-03-05 2002-07-01 Astrazeneca Ab Derivados de 4-anilinoquinazolina.
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
JP2001505779A (ja) * 1996-12-11 2001-05-08 スージェン・インコーポレーテッド Ｐｙｋ２関連産物および方法
US6818440B2 (en) * 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US7115710B2 (en) * 1997-06-11 2006-10-03 Sugen, Inc. Diagnosis and treatment of PTP related disorders
US6388063B1 (en) 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
US6495353B1 (en) 1998-01-21 2002-12-17 Sugen, Inc. Human orthologues of wart
AU3642499A (en) 1998-04-14 1999-11-01 Sugen, Inc. Ste20-related protein kinases
AU4317399A (en) 1998-05-28 1999-12-13 Parker Hughes Institute Quinazolines for treating brain tumor
US6800649B1 (en) 1998-06-30 2004-10-05 Parker Hughes Institute Method for inhibiting c-jun expression using JAK-3 inhibitors
EP1105378B1 (en) * 1998-08-21 2005-03-30 Parker Hughes Institute Quinazoline derivatives
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
US6258820B1 (en) 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
WO2001031005A2 (en) * 1999-10-22 2001-05-03 Pharmacia & Upjohn Company Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
US7364866B2 (en) * 1999-10-22 2008-04-29 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
CN100376567C (zh) 1999-11-05 2008-03-26 阿斯特拉曾尼卡有限公司 作为vegf抑制剂的喹唑啉衍生物
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors
US7160889B2 (en) * 2000-04-07 2007-01-09 Astrazeneca Ab Quinazoline compounds
US20050069976A1 (en) * 2001-02-14 2005-03-31 Peter Lind Protein-coupled receptor
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
DE60316810T2 (de) 2002-08-02 2008-07-17 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazole und ihre verwendung als c-kit inhibitoren
PL1684750T3 (pl) * 2003-10-23 2010-10-29 Ab Science 2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
EP2361624A1 (en) 2005-04-04 2011-08-31 AB Science Oxazole derivatives and their use as tyrosine kinase inhibitors
US8246966B2 (en) * 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
CA2663436A1 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008066755A2 (en) 2006-11-22 2008-06-05 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
SG177225A1 (en) * 2006-12-01 2012-01-30 Agency Science Tech & Res Cancer-related protein kinases
KR102061743B1 (ko) 2011-03-04 2020-01-03 뉴젠 세러퓨틱스 인코포레이티드 알킨 치환된 퀴나졸린 화합물 및 그것의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3298291A (en) * 1965-12-28 1967-01-17 Jack D Layton Paver screed assembly
US3455920A (en) * 1967-01-13 1969-07-15 Squibb & Sons Inc 2,3-dihydro-5 and 6-substituted-2-phenyl-4(1h)-quinazolinones
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
DE2050092C3 (de) 1970-10-13 1980-04-24 Bayer Ag, 5090 Leverkusen Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
AU438472B2 (en) * 1970-12-23 1973-08-09 Sumitomo Chemical Company, Limited Quinazolinone derivatives anda process for production thereof
JPS6011032B2 (ja) 1975-12-16 1985-03-22 大鵬薬品工業株式会社 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
YU42031B (en) 1988-04-30
GR75903B (online.php) 1984-08-02
FR2501207A1 (fr) 1982-09-10
LU83903A1 (fr) 1982-09-13
JPS57158780A (en) 1982-09-30
IL64875A0 (en) 1982-03-31
DE3203770C2 (de) 1993-11-04
DE3203770A1 (de) 1982-11-11
ATA39582A (de) 1985-10-15
KR880001852B1 (ko) 1988-09-22
SE461732B (sv) 1990-03-19
FI71559C (fi) 1987-01-19
CH647776A5 (de) 1985-02-15
ES509434A0 (es) 1983-02-16
IE820163L (en) 1982-09-06
JPH0337552B2 (online.php) 1991-06-05
GB2094295A (en) 1982-09-15
BE891936A (fr) 1982-07-28
PT74394A (en) 1982-03-01
FI820399L (fi) 1982-09-07
CA1163995A (en) 1984-03-20
NZ199576A (en) 1986-05-09
NL8200473A (nl) 1982-10-01
IT8247713A0 (it) 1982-02-03
KR830009050A (ko) 1983-12-17
ES8304095A1 (es) 1983-02-16
FI71559B (fi) 1986-10-10
HU189997B (en) 1986-08-28
CY1371A (en) 1987-08-07
KE3715A (en) 1987-04-16
SE8200526L (sv) 1982-09-07
PH18529A (en) 1985-08-02
DK50482A (da) 1982-09-07
GB2094295B (en) 1984-09-12
AU7998182A (en) 1982-09-09
PT74394B (en) 1984-10-22
SG30787G (en) 1988-09-16
US4343940A (en) 1982-08-10
IE52385B1 (en) 1987-10-14
AR231138A1 (es) 1984-09-28
IT1154272B (it) 1987-01-21
DK159442B (da) 1990-10-15
DK159442C (da) 1991-03-18
AT380476B (de) 1986-05-26
HK4588A (en) 1988-01-29
YU25682A (en) 1985-03-20
AU556099B2 (en) 1986-10-23
IT8247713A1 (it) 1983-08-03

Similar Documents

Publication Publication Date Title
DE3276321D1 (en) Continuous process for producing oxymethylene polymers
BE887193A (fr) Materiau composite et son procede de production
FR2558156B1 (fr) Procede de produ
BE878902A (fr) Procede de production d'alkylene-glycols
DE3262646D1 (en) Novel phosphorus-containing compounds and process for producing the same
DE3266045D1 (en) Process for the production of sugar ketals
GB2102024B (en) Process for the production of monascus-pigment
HUT37960A (en) Process for producing cyclic 9-comma above-thiapeptide-ergot-alkaloides
BE892269A (fr) Cataplasme analgesique et anti-inflammatoire et son procede de production
YU43107B (en) Process for producing sps-aze
DE3276431D1 (en) Process for producing 3-chloro-5-trifluoromethylpyridines
DE3269222D1 (en) Process for producing 5-halomethylfurfural
FR2501214B1 (fr) Procede de production de copolymere sequence de propylene
BE893707R (fr) Azabicyclohexanes et procede de leur preparation
EP0214995A4 (en) Immunotoxin and method of making.
FR2554322B1 (fr) Procede de production de caseinates
ZA825858B (en) Process for the production of 2- -d-ribofuranosylthiazole-4-carboxamide
FR2539757B1 (fr) Procede de production de bilirubine-oxydase
FR2477540B1 (fr) Procede de production de 5-chloro-b-trifluoromethylpyridines
DE3278134D1 (en) Process for the production of ultrahigh-modulus polymers
BE881609A (fr) Procede de production et d'isolement de methyltertiobutylether
FR2477559B1 (fr) Composition thermoplastique polyethylene-polybutadiene et son procede de production
YU43067B (en) Process for producing alpha-haloalkylamides
FR2560435B1 (fr) Tube photo-emeteur et son procede de production
DE3268121D1 (en) Process for producing peroxydicarconates

Legal Events

Date Code Title Description
ST Notification of lapse